Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen Xun

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|October 25, 2023
Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT SignalingYuchen Ye, Ya Fu, Caorui Lin, et al.
Journal of Clinical Laboratory Analysis|October 1, 2022
Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapyHongyan Shang, Yuhai Hu, Hongyan Guo, et al.
Microbiology Spectrum|October 26, 2023
A novel <i>TRIM22</i> gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis BLong Wang, Ni Lin, Yanfang Zhang, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 29, 2026
Metabolic inflexibility across heart failure phenotypes: mechanisms and type-specific therapeutic implicationsLi Chen, Xin-Rui Yang, Yan Jiang, et al.
Drug Design, Development and Therapy|July 6, 2026
Metabolomics-Driven Precision Prevention and Treatment of Heart Failure with Traditional Chinese Medicine: From Mechanistic Insights to Metabolic Network RegulationMing-Tai Chen, Yan Jiang, Shi-Yun Yang, et al.
Life Sciences|April 23, 2026
Toward metabolic precision medicine in heart failure: Timing, tissue specificity, and network reconstructionLi Chen, Xin-Rui Yang, Yan Jiang, et al.
Frontiers in Immunology|May 20, 2026
Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG-seronegative NMOSDZixin Chen, Yuchen Ye, Yanping Lan, et al.
Gut|July 11, 2025
Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-αCaorui Lin, Ying Huang, Ning Ran, et al.
International Journal of Cancer|August 11, 2024
S100a8/a9 regulated by LPS/TLR4 axis plays an important role in Salmonella-based tumor therapy and host defenseYanxia Guo, Yujie Sun, Zhongying Li, et al.
Gut|October 3, 2023
Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infectionCaorui Lin, Linjie Luo, Zhen Xun, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cellular and Molecular Gastroenterology and Hepatology|October 25, 2023
Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT SignalingYuchen Ye, Ya Fu, Caorui Lin, et al.
Journal of Clinical Laboratory Analysis|October 1, 2022
Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapyHongyan Shang, Yuhai Hu, Hongyan Guo, et al.
Microbiology Spectrum|October 26, 2023
A novel <i>TRIM22</i> gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis BLong Wang, Ni Lin, Yanfang Zhang, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 29, 2026
Metabolic inflexibility across heart failure phenotypes: mechanisms and type-specific therapeutic implicationsLi Chen, Xin-Rui Yang, Yan Jiang, et al.
Drug Design, Development and Therapy|July 6, 2026
Metabolomics-Driven Precision Prevention and Treatment of Heart Failure with Traditional Chinese Medicine: From Mechanistic Insights to Metabolic Network RegulationMing-Tai Chen, Yan Jiang, Shi-Yun Yang, et al.
Life Sciences|April 23, 2026
Toward metabolic precision medicine in heart failure: Timing, tissue specificity, and network reconstructionLi Chen, Xin-Rui Yang, Yan Jiang, et al.
Frontiers in Immunology|May 20, 2026
Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG-seronegative NMOSDZixin Chen, Yuchen Ye, Yanping Lan, et al.
Gut|July 11, 2025
Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-αCaorui Lin, Ying Huang, Ning Ran, et al.
International Journal of Cancer|August 11, 2024
S100a8/a9 regulated by LPS/TLR4 axis plays an important role in Salmonella-based tumor therapy and host defenseYanxia Guo, Yujie Sun, Zhongying Li, et al.
Gut|October 3, 2023
Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infectionCaorui Lin, Linjie Luo, Zhen Xun, et al.
Pageof 6